Malignant Hematologic Disorder
Conditions
Brief summary
The purpose of this study is to elucidate the factors which are associated with the diagnosis and predict prognosis and therapeutic targets by collecting specimens of tissue sample, peripheral blood, and bone marrow aspirates at the time of diagnosis or relapse/refractory in patients with malignant hematologic disorders except acute leukemia. This study is eligible for patients who are diagnosed with malignant hematologic disorders except acute leukemia or who will have diagnostic procedure with suspicion of having hematologic malignancy. Prospective cohort is for patients who are not in treatment for hematologic malignancy. Retrospective cohort is for patients who are diagnosed and in treatment.
Interventions
OTHERNo intervention
Sponsors
Yonsei University
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* The patients with malignant hematologic disorders except acute leukemia who are diagnosed pathologically according to the revised 2008 WHO classification of tumours of haematopoietic and lymphoid tissue or who will have diagnostic procedure with suspicion of having hematologic malignancy. * Any gender and age ≥ 19 years * Written informed consent * Diagnosed after 2005-01-01 in retrospective cohort group.
Exclusion criteria
* Patients who cannot understand or disagree the informed consent * Patients who diagnosed with acute leukemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the number of patients with malignant hematologic disorders to examine the new prognostic factors and therapeutic targets | 5 years |
Countries
South Korea
Outcome results
None listed